Landmark advance as malaria vaccine first to hit WHO goal
Issued on:
23/04/2021 - 18:58 Malaria killed at least four times as many more people in Africa last year as Covid did, Professor Adrian Hill said Olympia DE MAISMONT AFP/File 3 min
London (AFP)
A new malaria vaccine has proven 77 percent effective in trials on infants, British researchers said Friday, in what could prove to be a potential game-changer against the deadly mosquito-borne disease.
In a clinical trial in Burkina Faso, the Matrix-M vaccine developed by the University of Oxford s Jenner Institute was found to be 77 percent effective after 450 infants inoculated in 2019 were followed up for a year, the Oxford researchers said in a statement.
New Malaria Vaccine May Be The Key to Finally Controlling The Disease
sciencealert.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencealert.com Daily Mail and Mail on Sunday newspapers.
Landmark advance as malaria vaccine first to hit WHO goal
news24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news24.com Daily Mail and Mail on Sunday newspapers.
A first batch of COVID-19 vaccine doses was expected to arrive on Wednesday in war-torn northwestern Syria, where millions of people live in dire humanitarian conditions, a United Nations official said.
The 53,800 doses of the AstraZeneca vaccine were dispatched to the rebel-dominated region as part of the Covax facility, which ensures the world’s poorest economies get access to jabs for free.
“Once the vaccines arrive, we are prepared to start vaccination to priority groups through our implementing partners,” said Mahmoud Daher, a senior official with the UN’s World Health Organization (WHO).
The delivery will be the first to Syria as part of the Covax programme, which has already sent vaccine doses to more than 100 different territories worldwide.